Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.
Loo C, Glozier N, Barton D, Baune BT, Mills NT, Fitzgerald P, Glue P, Sarma S, Galvez-Ortiz V, Hadzi-Pavlovic D, Alonzo A, Dong V, Martin D, Nikolin S, Mitchell PB, Berk M, Carter G, Hackett M, Leyden J, Hood S, Somogyi AA, Lapidus K, Stratton E, Gainsford K, Garg D, Thornton NLR, Fourrier C, Richardson K, Rozakis D, Scaria A, Mihalopoulos C, Chatterton ML, McDonald WM, Boyce P, Holtzheimer PE, Kozel FA, Riva-Posse P, Rodgers A. Loo C, et al. Among authors: galvez ortiz v. Br J Psychiatry. 2023 Dec;223(6):533-541. doi: 10.1192/bjp.2023.79. Br J Psychiatry. 2023. PMID: 38108319 Free PMC article. Clinical Trial.
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUM.
Loo C, Glozier N, Barton D, Baune BT, Mills NT, Fitzgerald P, Glue P, Sarma S, Galvez-Ortiz V, Hadzi-Pavlovic D, Alonzo A, Dong V, Martin D, Nikolin S, Mitchell PB, Berk M, Carter G, Hackett M, Leyden J, Hood S, Somogyi AA, Lapidus K, Stratton E, Gainsford K, Garg D, Thornton NLR, Fourrier C, Richardson K, Rozakis D, Scaria A, Mihalopoulos C, Chatterton ML, McDonald WM, Boyce P, Holtzheimer PE, Kozel FA, Riva-Posse P, Rodgers A. Loo C, et al. Among authors: galvez ortiz v. Br J Psychiatry. 2024 Aug;225(2):349. doi: 10.1192/bjp.2024.189. Epub 2024 Oct 14. Br J Psychiatry. 2024. PMID: 39399907 No abstract available.
Safety outcomes of ketamine for treatment-resistant depression in clinical settings and development of the ketamine side effect tool-revised (KSET-R).
Bayes A, Cao TV, Barreiros AR, Massaneda-Tuneu C, Dong V, Thornton N, Glozier N, Beesley L, Moreno D, Gálvez-Ortiz V, Short B, Martin D, Loo C. Bayes A, et al. Among authors: galvez ortiz v. Psychiatry Res. 2025 Feb;344:116334. doi: 10.1016/j.psychres.2024.116334. Epub 2024 Dec 20. Psychiatry Res. 2025. PMID: 39721099
Propofol and thiopental as anesthetic agents in electroconvulsive therapy: a retrospective study in major depression.
Martínez-Amorós E, Gálvez Ortiz V, Porter Moli M, Llorens Capdevila M, Cerrillo Albaigés E, Garcia-Parés G, Cardoner Álvarez N, Urretavizcaya Sarachaga M. Martínez-Amorós E, et al. Among authors: galvez ortiz v. Rev Psiquiatr Salud Ment. 2014 Jan-Mar;7(1):42-7. doi: 10.1016/j.rpsm.2013.01.002. Epub 2013 Mar 11. Rev Psiquiatr Salud Ment. 2014. PMID: 23490495 English, Spanish.